Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study
Dana Chase, Helen Q Huang, Bradley J Monk, Lois Michelle Ramondetta, Richard T Penson, Karen Gil, Lisa M Landrum, Mario Leitao, Ana Oaknin, Warner K Huh, Heather L Pulaski, Katina Robison, Saketh R Guntupalli, Debra Richardson, Ritu Salani, Michael W Sill, Lari B Wenzel, Krishnansu Sujata Tewari
International Journal of Gynecologic Cancer May 2020, 30 (5) 596-601; DOI: 10.1136/ijgc-2019-000869
